Chief of Urologic Surgery / Beth Israel Deaconess Med Center
Beth Israel Deaconess Med Center/Harvard Medical School
Aria F. Olumi, MD, serves as Chief of Urologic Surgery at Beth Israel Deaconess Medical Center and is the endowed Janet and William DeWolf Professor of Surgery at Harvard Medical School. As a physician scientist, he is also the Chair of American Urological Association (AUA) Research Council. His clinical activities are focused on urologic oncology and surgical management of kidney, bladder and prostate cancer. Previously, he has held the role of the Residency Program Director at Massachusetts General Hospital and the Director of the Combined Harvard Urologic Oncology Fellowship Program.
His NIH funded laboratory is focused on providing personalized care for prostatic diseases. His lab has shown that the 5-alpha reductase 2 (5AR2) gene, an important gene that is responsible for normal prostatic development and growth, and a target of the commonly used 5-alpha reductase inhibitors (finasteride or dutasteride), is not expressed in 30% of adult men. The Olumi lab has defined the epigenetic mechanisms that lead to variable expression of the 5AR2 gene in adult prostates. Their findings have broad implications that can explain the variable growth patterns of the prostate gland and the reason for resistance to the therapeutic effects of 5-alpha reductase inhibitors.
As Chair of the AUA Research Council, his goal is to enhance the research activities for the urologic community and increase the educated workforce of urologic researchers who can effectively study urologic diseases with the ultimate goal of reducing burden of disease for patients. Through advocacy, education and promotion of grant funding mechanisms for new and established investigators he is committed to promote the research mission of the urologic community.
Disclosure information not submitted.
Monday, May 1, 2023
7:00 AM – 9:00 AM CST